Period Ending | Dec 31, 2009 | Dec 31, 2008 | Dec 28, 2007 |
Total Revenue
|
1,195,413
|
1,367,224
|
1,263,548
| Cost of Revenue | 396,584 | 449,750 | 448,025 | |
Gross Profit
|
798,829
|
917,474
|
815,523
| |
|
Operating Expenses |
|
Research Development | 260,208 | 257,717 | 265,581 |
|
Selling General and Administrative | 234,074 | 255,391 | 274,989 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
304,547
|
404,366
|
274,953
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,083 | 30,300 | 62,675 |
|
Earnings Before Interest And Taxes | 310,630 | 434,666 | 337,628 |
|
Interest Expense | 5,092 | 15,492 |
-
|
|
Income Before Tax | 305,538 | 419,174 | 337,628 |
|
Income Tax Expense | 54,476 | 59,523 | 47,605 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 251,062 | 359,651 | 290,023 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
251,062
|
359,651
|
290,023
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
$251,062
|
$359,651
|
$290,023
|
|